Carroll Introduces Legislation to Improve Gluten Labeling for Medications

SPRINGFIELD, Ill. – Manufacturers of gluten-containing medications would be required to label their products as such under legislation recently introduced by state Rep. Jonathan Carroll, D-Northbrook. 

“For people with celiac disease who follow a gluten-free diet for health reasons, some medications can be dangerous rather than helpful,” said Carroll. “We have clear guidelines in place to help people find gluten-free food products, and the same should be true of prescription and over-the counter-drugs containing ingredients that could trigger an adverse reaction.”

Under Carroll’s House Bill 4471, gluten-containing drugs that are not accurately labled would be deemed misbranded under the Illinois Food, Drug and Cosmetic Act. A strong advocate for allergy awareness and safe practices, Carroll previously passed legislation requiring insurers to cover epinephrine injectors, as well as requiring food manufacturers to disclose sesame as an allergen on product labels.

“As food allergies and intolerances are becoming more common, it’s important that manufacturers keep up with consumers’ need for clear ingredient labeling,” said Carroll. “This legislation ensures drug manufacturers are transparent about whether their products are safe for a gluten-free diet, further helping celiac patients manage their disease.”